Dr. Ritz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
M530, Dana-Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-3465Fax+1 617-632-5167- Is this information wrong?
Summary
- Dr. Jerome Ritz is a hematologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Dana-Farber Cancer Institute. He is Professor of Medicine at Harvard Medical School. He received his medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 45 years. He specializes in hematologic oncology and is experienced in hematologic oncology, hematopoietic stem cell transplantation and cellular therapies. He is currently Executive Director of the Connell and O'Reilly Families Cell Manipulation Core Facility.
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1972 - 1975
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
- MA State Medical License 1976 - 2025
- CO State Medical License 1975 - 1980
- WI State Medical License 1973 - 1979
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2021
- Elected Member The American Society for Clinical Investigation, 1990
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Nonpathogenicengineered to surface display cytokines as a new platform for immunotherapy.Shaobo Yang, Michal Sheffer, Isabel E Kaplan, Zongqi Wang, Mubin Tarannum, Khanhlinh Dinh, Yasmin Abdulhamid, Roman Shapiro, Rebecca Porter, Robert Soiffer, Jerome Rit...> ;Research Square. 2024 Mar 22
- Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping.Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zar...> ;Nature Medicine. 2024 Mar 1
- 1 citationsProphylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.Garcia, J., Kim, H., Murdock, H., Ansuinelli, M., Brock, J., Cutler, C., Gooptu, M., Ho, V., Koreth, J., Nikiforow, S., Romee, R., Shapiro, R., DeAngelo, D., Stone, R....> ;Blood Advances. 2024 Feb 27
- Join now to see all
Journal Articles
- Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host DiseaseJoseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood
- Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell ResponseIsaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology
Abstracts/Posters
- Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...Jerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T CellsJerome Ritz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
- National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory BoardOctober 25th, 2022
- National Cancer Center Announces Recipients of 2021-22 Research Fellowship AwardsJune 16th, 2021
- Equillium Announces Positive Data for Itolizumab in Acute Graft-Versus-Host Disease in Two Presentations at the 47th Annual Meeting of the European Society for Blood and Marrow TransplantationMarch 15th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: